In order to comprehensively address health issues, we seek collaborative partnerships with healthcare decision-makers. We work together to develop innovative solutions that contribute to improving patients' health in Switzerland.

Our initiatives and projects

All.Can Schweiz

All.Can Switzerland works with stakeholders to develop solutions for sustainable cancer care in Switzerland. MSD is a founding member of this initiative.

Improvement in health literacy

MSD has been committed to strengthening health literacy for decades, both locally and globally. In Switzerland, MSD joined forces with the founding partners, amongst others FMH and Health Promotion Switzerland, into 2010 to create the “Allianz Gesundheitskompetenz” (Health Literacy Alliance). The alliance is a networking platform for stakeholders from the areas of health, science and politics, promoting the issue at the strategic level, supporting the implementation of initiatives and awarding a regular prize for innovative implementation projects.

Learn more (Information in German)

allianz q – quality before cost in healthcare

allianz q is an interest group of stakeholders in the area of healthcare. Functioning like a think tank, allianz q brings together experts from a wide range of healthcare fields. The shared principles and mode of cooperation are defined in the mission statement. MSD is a member and has been supporting allianz q since the beginning.

Learn more (Information in German)

Raising awareness for back pain and rheumatic diseases

www.ruecken-schmerz.ch is part of an educational campaign of the Swiss Bechterev's Disease Association. Currently, the focus is on the video series "Explico". It provides information on topics related to Bechterev's disease in a fresh and attractive way.

www.rheumafit.ch is the first online platform with exercise videos for counteracting the rheumatic disease ankylosing spondylitis. MSD has worked closely with the Swiss Bechterew's Disease Association for many years and has supported the development of both online platforms.

Learn more ruecken-schmerz.ch Learn more rheumafit.ch

Patient app for treatment monitoring

iBDialog monthly was developed for patients in Switzerland by leading gastroenterologists at IBDnet and the patient organization Crohn Colitis Schweiz (CCS) in close cooperation with MSD. The project pursued a common goal: to develop a practical patient app that allows patients and gastroenterologists to easily monitor treatments for chronic infectious intestinal disorders.

Learn more IBDnet Learn more CCS Learn more iBDialog (German version)

Patient app for documenting disease activity and treatment adherence

The jointly developed patient app provides rheumatologists and patients with an easy-to-use, modern platform for documenting disease activity and treatment adherence between check-ups. This data helps the attending physician work with the patient to evaluate the course of the disease more accurately and to design the treatment more effectively. The app was developed by MSD in close cooperation with the SCQM Foundation from 2016 to late 2018 and was then continued by SCQM as ‘mySCQM.’ The collected data aid research in areas such as optimizing medicinal treatment for rheumatic inflammatory diseases.

Learn more

Swiss Congress for Health Economics and Health Sciences

Experts from a wide range of fields have been meeting since 2004 at the annual Swiss Congress for Health Economics and Health Science to debate and discuss the future of the Swiss healthcare system. MSD initiated this Congress and has supported it from the outset.

Learn more (Information in German)

Principal partner of the symposium "Trendtage Gesundheit Luzern" ("Lucerne Health Trend Days")

Every year, more than 600 decision-makers and influencers in the areas of medicine, science, economics and politics meet to discuss trends and perspectives in the Swiss healthcare system at the Trendtage Gesundheit at KKL Lucerne. As a Lucerne-based biopharmaceutical company, MSD has supported this leading national industry event for many years and has been a principal partner since 2013. MSD is a member of the advisory board and gives input on identifying annual trends and defining the symposium content.

Learn more (Information in German)

We take responsibility

Learn more about our global corporate responsibility approach and our social engagement in Switzerland.

Learn more

Transparency

Transparency is one of the cornerstones of MSD's corporate reputation. We support the efforts of the European Federation of Pharmaceutical Industries and Associations (EFPIA) to increase transparency in the pharmaceutical industry.


CH-NON-00947, 12/2020